These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15373969)

  • 61. [Bacterial endotoxins and immune complexes].
    Aoki S
    Saishin Igaku; 1970 Sep; 25(9):1858-69. PubMed ID: 4917831
    [No Abstract]   [Full Text] [Related]  

  • 62. Generation of αCD11b-CpG antibody conjugates for the targeted stimulation of myeloid cells.
    Balneger N; Kroesen M; Lindau D; Wassink M; Boon L; den Brok MH; Büll C; Adema GJ
    J Control Release; 2021 Apr; 332():148-159. PubMed ID: 33609622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blood serum DNA in patients with rheumatoid arthritis is considerably enriched with fragments of ribosomal repeats containing immunostimulatory CpG-motifs.
    Veiko NN; Shubaeva NO; Ivanova SM; Speranskii AI; Lyapunova NA; Spitkovskii DM
    Bull Exp Biol Med; 2006 Sep; 142(3):313-6. PubMed ID: 17426837
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Inhibition of antibody-dependent cell-mediated cytotoxicity (CIA) as a technic for measuring circulating immune complexes in autoimmune diseases].
    Guerra F; Bellido C; Aguilar R; Jurado R; Garrido F; Sánchez Guijo P
    Rev Clin Esp; 1981 Dec; 163(6):397-402. PubMed ID: 7342202
    [No Abstract]   [Full Text] [Related]  

  • 65. Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.
    Putta MR; Bhagat L; Wang D; Zhu FG; Kandimalla ER; Agrawal S
    ACS Med Chem Lett; 2013 Feb; 4(2):302-5. PubMed ID: 24900663
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Role of immune complexes in the development of inflammatory vascular diseases].
    Masłowski L
    Kardiol Pol; 1987; 30(4):218-25. PubMed ID: 3656874
    [No Abstract]   [Full Text] [Related]  

  • 67. [Influence of rheumatoid factors on the anti-complement activity of solubilized immune complex].
    Yoshio T; Noguchi E; Yoshida K; Yoshinoya S; Yukiyama Y; Hirose S
    Ryumachi; 1984 Aug; 24(4):256-62. PubMed ID: 6515504
    [No Abstract]   [Full Text] [Related]  

  • 68. [Systemic rheumatic diseases and immune complexes].
    Machtey I
    Harefuah; 1982 Sep; 103(5-6):128-9. PubMed ID: 6984838
    [No Abstract]   [Full Text] [Related]  

  • 69. Modulation of toll-like receptor signaling by antimicrobial peptides.
    Lee EY; Lee MW; Wong GCL
    Semin Cell Dev Biol; 2019 Apr; 88():173-184. PubMed ID: 29432957
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The protective effect of the anti-Toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA.
    Murakami Y; Fukui R; Motoi Y; Shibata T; Saitoh SI; Sato R; Miyake K
    Sci Rep; 2017 Mar; 7():44042. PubMed ID: 28266597
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.
    Gülden E; Ihira M; Ohashi A; Reinbeck AL; Freudenberg MA; Kolb H; Burkart V
    PLoS One; 2013; 8(9):e75385. PubMed ID: 24086519
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of immunostimulatory nucleic acids in septic shock.
    Bleiblo F; Michael P; Brabant D; Ramana CV; Tai T; Saleh M; Parrillo JE; Kumar A; Kumar A
    Int J Clin Exp Med; 2012; 5(1):1-23. PubMed ID: 22328944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes.
    Avalos AM; Kiefer K; Tian J; Christensen S; Shlomchik M; Coyle AJ; Marshak-Rothstein A
    Autoimmunity; 2010 Feb; 43(1):103-10. PubMed ID: 20014975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.
    Uccellini MB; Busconi L; Green NM; Busto P; Christensen SR; Shlomchik MJ; Marshak-Rothstein A; Viglianti GA
    J Immunol; 2008 Nov; 181(9):5875-84. PubMed ID: 18941176
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
    Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
    Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The regulation of autoreactive B cells during innate immune responses.
    Vilen BJ; Rutan JA
    Immunol Res; 2008; 41(3):295-309. PubMed ID: 18704765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.
    Herlands RA; William J; Hershberg U; Shlomchik MJ
    Eur J Immunol; 2007 Dec; 37(12):3339-51. PubMed ID: 18034429
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Manifold mechanisms of Toll-like receptor-ligand recognition.
    Ishii KJ; Coban C; Akira S
    J Clin Immunol; 2005 Nov; 25(6):511-21. PubMed ID: 16380815
    [TBL] [Abstract][Full Text] [Related]  

  • 79. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
    Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
    J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.
    Christensen SR; Kashgarian M; Alexopoulou L; Flavell RA; Akira S; Shlomchik MJ
    J Exp Med; 2005 Jul; 202(2):321-31. PubMed ID: 16027240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.